無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

粒子治療の世界市場:タイプ別(重鉄、プロトン治療)、製品別(サイクロトロン、シンクロトロン、シンクロサイクロトロン)、サービス別、システム別(シングルルーム、マルチルーム)、癌タイプ別(小児癌、前立腺癌、乳癌)、用途別(治療、研究) - 2023年までの予測

Particle Therapy Market by Type (Heavy Ion, Proton Therapy), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate, Breast), Application (Treatment, Research) - Forecast to 2023

発行 MarketsandMarkets 商品コード 747485
出版日 ページ情報 英文 139 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.61円で換算しております。
Back to Top
粒子治療の世界市場:タイプ別(重鉄、プロトン治療)、製品別(サイクロトロン、シンクロトロン、シンクロサイクロトロン)、サービス別、システム別(シングルルーム、マルチルーム)、癌タイプ別(小児癌、前立腺癌、乳癌)、用途別(治療、研究) - 2023年までの予測 Particle Therapy Market by Type (Heavy Ion, Proton Therapy), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate, Breast), Application (Treatment, Research) - Forecast to 2023
出版日: 2018年11月16日 ページ情報: 英文 139 Pages
概要

世界の粒子治療市場は2018年の8億6,500万米ドルからCAGR9.3%で拡大し、2023年までに13億4,900万米ドルに拡大すると予測されています。粒子治療の様々な利点、癌罹患率の上昇、治験における粒子治療の導入増加、世界的粒子治療センターの増加などが市場の成長を牽引しています。

当レポートでは、世界の粒子治療市場について調査し、市場の動向とセグメント別概要、地域別動向、および市場に参入主要企業のプロファイルと競合動向についてまとめています。

FIGURE 13 PARTICLE THERAPY MARKET

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 プレミアウインサイト

  • 市場概要
  • 製品・サービス別市場
  • タイプ別市場
  • 癌タイプ別市場
  • 用途別市場
  • 地域別市場

第5章 市場概要

  • イントロダクション
  • 市場動向
    • 促進因子
    • 阻害因子
    • 業界動向

第6章 タイプ別市場

  • イントロダクション
  • プロトン治療
  • 重鉄治療

第7章 製品・サービス別市場

  • イントロダクション
  • 製品
    • サイクロトロン
    • シンクロトロン
    • シンクロサイクロトロン
  • サービス

第8章 システム別市場

  • イントロダクション
  • マルチルームシステム
  • シングルルームシステム

第9章 癌タイプ別市場

  • イントロダクション
    • 小児癌
    • 前立腺癌
    • 肺癌
    • 乳癌
    • 頭部・頸部癌
    • その他

第10章 用途別市場

  • イントロダクション
  • 治療
  • 研究

第11章 地域別市場

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第12章 競合環境

  • イントロダクション
  • 市場シェア分析
  • 競合動向分析
  • 競合シナリオ

第13章 企業プロファイル

第14章 付録

図表

LIST OF TABLES

  • TABLE 1: PARTICLE THERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 2: PROTON THERAPY MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 3: HEAVY ION THERAPY MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 4: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 5: PARTICLE THERAPY PRODUCT & SERVICE MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 6: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 7: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016-2023 (UNITS)
  • TABLE 8: PARTICLE THERAPY PRODUCTS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 9: CYCLOTRONS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 10: CYCLOTRONS MARKET, BY REGION, 2016-2023 (UNITS)
  • TABLE 11: SYNCHROTRONS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 12: SYNCHROTRONS MARKET, BY REGION, 2016-2023 (UNITS)
  • TABLE 13: SYNCHROCYCLOTRONS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 14: SYNCHROCYCLOTRONS MARKET, BY REGION, 2016-2023 (UNITS)
  • TABLE 15: PARTICLE THERAPY SERVICES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 16: PARTICLE THERAPY MARKET, BY SYSTEM, 2016-2023 (USD MILLION)
  • TABLE 17: PARTICLE THERAPY MARKET FOR MULTI-ROOM SYSTEMS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 18: PARTICLE THERAPY MARKET FOR SINGLE-ROOM SYSTEMS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 19: PARTICLE THERAPY MARKET, BY CANCER TYPE, 2016-2023 (USD MILLION)
  • TABLE 20: PARTICLE THERAPY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 21: PARTICLE THERAPY MARKET FOR TREATMENT APPLICATIONS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 22: PARTICLE THERAPY MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 23: PARTICLE THERAPY MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 24: NORTH AMERICA: PARTICLE THERAPY MARKET, BY COUNTRY, 2016-2018 (USD MILLION)
  • TABLE 25: NORTH AMERICA: PARTICLE THERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 26: NORTH AMERICA: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 27: NORTH AMERICA: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 28: NORTH AMERICA: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016-2023 (UNITS)
  • TABLE 29: NORTH AMERICA: PARTICLE THERAPY MARKET, BY SYSTEM, 2016-2023 (USD MILLION)
  • TABLE 30: NORTH AMERICA: PARTICLE THERAPY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 31: US: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE, 2016-2018 (USD MILLION)
  • TABLE 32: US: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016-2018 (USD MILLION)
  • TABLE 33: US: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016-2018 (UNITS)
  • TABLE 34: CANADA: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE, 2016-2018 (USD MILLION)
  • TABLE 35: CANADA: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016-2018 (USD MILLION)
  • TABLE 36: CANADA: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016-2018 (UNITS)
  • TABLE 37: EUROPE: PARTICLE THERAPY MARKET, BY COUNTRY, 2016-2018 (USD MILLION)
  • TABLE 38: EUROPE: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 39: EUROPE: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 40: EUROPE: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016-2023 (UNITS)
  • TABLE 41: EUROPE: PARTICLE THERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 42: EUROPE: PARTICLE THERAPY MARKET, BY SYSTEM, 2016-2023 (USD MILLION)
  • TABLE 43: EUROPE: PARTICLE THERAPY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 44: FRANCE: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE, 2016-2018 (USD MILLION)
  • TABLE 45: FRANCE: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016-2018 (USD MILLION)
  • TABLE 46: FRANCE: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016-2018 (UNITS)
  • TABLE 47: GERMANY: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE, 2016-2018 (USD MILLION)
  • TABLE 48: GERMANY: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016-2018 (USD MILLION)
  • TABLE 49: GERMANY: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016-2018 (UNITS)
  • TABLE 50: UK: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE, 2016-2018 (USD MILLION)
  • TABLE 51: UK: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016-2018 (USD MILLION)
  • TABLE 52: UK: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016-2018 (UNITS)
  • TABLE 53: ROE: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE, 2016-2018 (USD MILLION)
  • TABLE 54: ROE: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016-2018 (USD MILLION)
  • TABLE 55: ROE: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016-2018 (UNITS)
  • TABLE 56: ASIA PACIFIC: PARTICLE THERAPY MARKET, BY COUNTRY, 2016-2018 (USD MILLION)
  • TABLE 57: ASIA PACIFIC: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 58: ASIA PACIFIC: PARTICLE THERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 59: ASIA PACIFIC: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 60: ASIA PACIFIC: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016-2023 (UNITS)
  • TABLE 61: ASIA PACIFIC: PARTICLE THERAPY MARKET, BY SYSTEM, 2016-2023 (USD MILLION)
  • TABLE 62: ASIA PACIFIC: PARTICLE THERAPY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 63: JAPAN: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE, 2016-2018 (USD MILLION)
  • TABLE 64: JAPAN: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016-2018 (USD MILLION)
  • TABLE 65: JAPAN: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016-2018 (UNITS)
  • TABLE 66: CHINA: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE, 2016-2018 (USD MILLION)
  • TABLE 67: CHINA: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016-2018 (USD MILLION)
  • TABLE 68: CHINA: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016-2018 (UNITS)
  • TABLE 69: INDIA: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE, 2016-2018 (USD MILLION)
  • TABLE 70: INDIA: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016-2018 (USD MILLION)
  • TABLE 71: INDIA: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016-2018 (UNITS)
  • TABLE 72: ROAPAC: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE, 2016-2018 (USD MILLION)
  • TABLE 73: ROAPAC: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016-2018 (USD MILLION)
  • TABLE 74: ROAPAC: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016-2018 (UNITS)
  • TABLE 75: ROW: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 76: ROW: PARTICLE THERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 77: ROW: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 78: ROW: PARTICLE THERAPY PRODUCTS MARKET, BY TYPE, 2016-2023 (UNITS)
  • TABLE 79: ROW: PARTICLE THERAPY MARKET, BY SYSTEM, 2016-2023 (USD MILLION)
  • TABLE 80: ROW: PARTICLE THERAPY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: PARTICLE THERAPY MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BOTTOM-UP APPROACH MARKET SIZE ESTIMATION: PARTICLE THERAPY MARKET
  • FIGURE 4: TOP-DOWN APPROACH MARKET SIZE ESTIMATION: PARTICLE THERAPY PRODUCT MARKET
  • FIGURE 5: TOP-DOWN APPROACH MARKET SIZE ESTIMATION: PARTICLE THERAPY SERVICES MARKET
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: PARTICLE THERAPY MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 8: PARTICLE THERAPY PRODUCTS MARKET SHARE, BY TYPE, 2018 VS. 2023
  • FIGURE 9: REGIONAL ANALYSIS: PARTICLE THERAPY MARKET, BY SYSTEM, 2018 (USD MILLION)
  • FIGURE 10: PARTICLE THERAPY MARKET SHARE, BY CANCER TYPE, 2018 VS. 2023
  • FIGURE 11: PARTICLE THERAPY MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION)
  • FIGURE 12: PARTICLE THERAPY MARKET: GEOGRAPHICAL SNAPSHOT
  • FIGURE 13: INCREASING CANCER PREVALENCE IS DRIVING GROWTH OF THE PARTICLE THERAPY MARKET
  • FIGURE 14: SERVICES SEGMENT TO WITNESS HIGH GROWTH IN THE APAC MARKET DURING THE FORECAST PERIOD
  • FIGURE 15: PROTON THERAPY WILL DOMINATE THE MARKET DURING THE FORECAST PERIOD (2018-2023)
  • FIGURE 16: PEDIATRIC CANCER SEGMENT WILL GROW AT THE FASTEST RATE IN THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 17: TREATMENT APPLICATION SEGMENT IS ESTIMATED TO HOLD THE LARGEST SHARE OF THE MARKET GLOBALLY IN 2018
  • FIGURE 18: ASIA PACIFIC TO WITNESS FASTEST GROWTH DURING THE FORECAST PERIOD (2018-2023)
  • FIGURE 20: GROWING INCIDENCE OF CANCER, BY REGION, 2012-2020 (THOUSANDS)
  • FIGURE 21: PROTON THERAPY SEGMENT TO DOMINATE THE PARTICLE THERAPY MARKET DURING THE FORECAST PERIOD
  • FIGURE 22: CYCLOTRONS SEGMENT TO DOMINATE THE PARTICLE THERAPY PRODUCTS MARKET
  • FIGURE 23: MULTI-ROOM SYSTEMS SEGMENT TO DOMINATE THE PARTICLE THERAPY MARKET DURING THE FORECAST PERIOD
  • FIGURE 24: PEDIATRIC CANCER SEGMENT TO WITNESS HIGHEST GROWTH IN THE PARTICLE THERAPY MARKET DURING THE FORECAST PERIOD
  • FIGURE 25: TREATMENT APPLICATIONS TO DOMINATE THE PARTICLE THERAPY MARKET DURING THE FORECAST PERIOD
  • FIGURE 26: ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE PARTICLE THERAPY MARKET DURING THE FORECAST PERIOD
  • FIGURE 27: NUMBER OF PARTICLE THERAPY FACILITIES PRESENT (AS OF OCTOBER 2018) & UNDER CONSTRUCTION ACROSS THE GLOBE
  • FIGURE 28: NORTH AMERICA: PARTICLE THERAPY MARKET SNAPSHOT
  • FIGURE 29: EUROPE: PARTICLE THERAPY MARKET SNAPSHOT
  • FIGURE 30: ASIA PACIFIC: PARTICLE THERAPY MARKET SNAPSHOT
  • FIGURE 31: ROW: PARTICLE THERAPY MARKET SNAPSHOT
  • FIGURE 32: KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE PARTICLE THERAPY MARKET, 2015-2018
  • FIGURE 33: PARTICLE THERAPY MARKET SHARE, BY KEY PLAYER, 2017
  • FIGURE 34: VARIAN MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT
  • FIGURE 35: ION BEAM APPLICATIONS SA: COMPANY SNAPSHOT
  • FIGURE 36: SUMITOMO HEAVY INDUSTRIES: COMPANY SNAPSHOT
  • FIGURE 37: HITACHI, LTD.: COMPANY SNAPSHOT
目次
Product Code: MD 6747

"The particle therapy market is projected to grow at a CAGR of 9.3% during the forecast period"

The global particle therapy market is projected to reach USD 1,349 million by 2023 from USD 865 million in 2018, at a CAGR of 9.3%. The growth of this market is largely driven by factors such as the various advantages offered by particle therapy over photon therapy, growing global prevalence of cancer, increasing adoption of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide.

"The cyclotrons segment is expected to account for the largest market share during the forecast period"

Based on type, the particle therapy products market is segmented into cyclotrons, synchrotrons, and synchrocyclotrons. The cyclotrons segment is expected to account for the largest share of this market in 2018. The development of technologically advanced systems, advantages offered by cyclotrons over other accelerators, and the growing adoption of cyclotrons among users are the major factors driving the growth of this market segment. Furthermore, the leading player in the particle therapy market with the strongest global footprint-IBA-majorly manufactures cyclotrons. This has greatly boosted the adoption of these products.

"The research applications segment is estimated to grow at the highest rate during the forecast period"

On the basis of application, the particle therapy market has been segmented into treatment and research applications. The research applications segment is estimated to grow at the highest rate during the forecast period due to factors such as the growing awareness about the research applications of particle therapy systems, development of cost-effective and technologically advanced diagnostic and therapeutic particle therapy systems, and the increasing industry-academia collaborations in the field of research.

"North America to account for the second-largest share of the global market in 2018"

The particle therapy market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World. North America is expected to account for the second-largest share of the global particle therapy market in 2018. Technological advancements in the field of particle therapy, the rising incidence of cancer, easy accessibility to treatments, and the high adoption of advanced diagnostic technologies (owing to the significant per capita annual healthcare expenditure by the US and Canadian governments) are some of the key factors supporting the growth of the North American market. Furthermore, favorable government initiatives that are creating awareness and promoting the adoption of proton therapy among key end users are some of the other major factors driving the growth of the particle therapy market in North America.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1-25%, Tier 2-30%, and Tier 3-45%
  • By Designation: C-level-26%, Director-level-30%, and Others-44%
  • By Region: North America-35%, Europe-26%, APAC-23%, and RoW-16%

The major players in the market include: Ion Beam Applications SA (Belgium), Varian Medical Systems, Inc. (US), Hitachi, Ltd. (Japan), Provision Healthcare (US), Mevion Medical Systems, Inc. (US), Sumitomo Heavy Industries, Ltd. (Japan), Optivus Proton Therapy, Inc. (US), ProTom International, Inc. (US), Advanced Oncotherapy Plc. (UK), and Danfysik A/S (Denmark).

Research Coverage:

This report studies the particle therapy market based on type, product & service, system, cancer type, application, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions (and the respective countries in these regions).

Key Benefits of Buying the Report:

This report focuses on various levels of analysis-industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the particle therapy market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Breakdown of primaries
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. PRODUCT-BASED MARKET ESTIMATION
    • 2.2.2. VOLUME-BASED MARKET ESTIMATION
    • 2.2.3. PRIMARY RESEARCH VALIDATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. RESEARCH LIMITATIONS AND ASSUMPTIONS
    • 2.4.1. LIMITATIONS
    • 2.4.2. ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. PARTICLE THERAPY: MARKET OVERVIEW
  • 4.2. REGIONAL ANALYSIS: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE
  • 4.3. PARTICLE THERAPY MARKET SIZE, BY TYPE
  • 4.4. PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE
  • 4.5. REGIONAL ANALYSIS: PARTICLE THERAPY MARKET, BY APPLICATION
  • 4.6. PARTICLE THERAPY MARKET, BY REGION

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Advantages offered by particle therapy over photon therapy
      • 5.2.1.2. Growing global prevalence of cancer
      • 5.2.1.3. Growing adoption of particle therapy in clinical trials
      • 5.2.1.4. Increasing number of particle therapy centers worldwide
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Infrastructural challenges in healthcare facilities
      • 5.2.2.2. Affordability and accessibility of treatments
      • 5.2.2.3. Unfavorable reimbursement policies and limited insurance coverage for particle therapy
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Emerging markets
    • 5.2.4. INDUSTRY TRENDS
      • 5.2.4.1. GROWING ADOPTION OF PENCIL-BEAM SCANNING

6. PARTICLE THERAPY MARKET, BY TYPE

  • 6.1. INTRODUCTION
  • 6.2. PROTON THERAPY
    • 6.2.1. PROTON THERAPY IS INCREASINGLY BEING ADOPTED AS A PRIMARY TREATMENT MODE FOR VARIOUS CANCER TYPES
  • 6.3. HEAVY ION THERAPY
    • 6.3.1. THE USE OF HEAVY ION THERAPY IS STILL IN THE EXPERIMENTAL PHASE ACROSS MANY REGIONS

7. PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE

  • 7.1. INTRODUCTION
  • 7.2. PRODUCTS
    • 7.2.1. CYCLOTRONS
      • 7.2.1.1. Leading players in the particle therapy market mainly manufacture cyclotrons
    • 7.2.2. SYNCHROTRONS
      • 7.2.2.1. Increasing investments into the development of synchrotron facilities are contributing to market growth
    • 7.2.3. SYNCHROCYCLOTRONS
      • 7.2.3.1. The high space requirements of synchrocyclotrons are limiting their widespread adoption
  • 7.3. SERVICES

8. PARTICLE THERAPY MARKET, BY SYSTEM

  • 8.1. INTRODUCTION
  • 8.2. MULTI-ROOM SYSTEMS
    • 8.2.1. LOWER SHIELDING REQUIREMENTS AND FASTER BEAM-SWITCHING CAPABILITIES OF MULTI-ROOM SYSTEMS ARE INCREASING INTEREST AMONG END USERS
  • 8.3. SINGLE-ROOM SYSTEMS
    • 8.3.1. COMPACT STRUCTURE AND REDUCED CAPITAL COSTS ARE LEADING TO HIGH GROWTH OF SINGLE-ROOM SYSTEMS

9. PARTICLE THERAPY MARKET, BY CANCER TYPE

  • 9.1. INTRODUCTION
    • 9.1.1. PEDIATRIC CANCER
      • 9.1.1.1. BETTER CONTROL OF RADIATION WITH PARTICLE THERAPY MAKES IT THE MOST SUITABLE TREATMENT MODE FOR PEDIATRIC CANCER
    • 9.1.2. PROSTATE CANCER
      • 9.1.2.1. PARTICLE THERAPY OFFERS A MINIMALLY INVASIVE ALTERNATIVE WITH INCREASED ACCURACY FOR PROSTATE CANCER TREATMENT
    • 9.1.3. LUNG CANCER
      • 9.1.3.1. RISING NUMBER OF CLINICAL TRIALS TO OPTIMIZE THE USE OF PARTICLE THERAPY FOR LUNG CANCER IS DRIVING THE GROWTH OF THE MARKET
    • 9.1.4. BREAST CANCER
      • 9.1.4.1. LIMITED RADIATION EXPOSURE WITH REDUCED SIDE-EFFECTS IS INCREASING THE ADOPTION OF PARTICLE THERAPY FOR BREAST CANCER
    • 9.1.5. HEAD AND NECK CANCER
      • 9.1.5.1. THE USE OF PENCIL-BEAM SCANNING FOR PROTON THERAPY SUPPORTS MARKET GROWTH FOR THIS SEGMENT
    • 9.1.6. OTHER CANCERS

10. PARTICLE THERAPY MARKET, BY APPLICATION

  • 10.1. INTRODUCTION
  • 10.2. TREATMENT APPLICATIONS
    • 10.2.1. INTRODUCTION OF SMALL FOOTPRINT SINGLE-ROOM PARTICLE THERAPY CENTRES IS PROMOTING THE ADOPTION OF PARTICLE THERAPY FOR CANCER TREATMENT
  • 10.3. RESEARCH APPLICATIONS
    • 10.3.1. INCREASING AVAILABILITY OF FUNDING FOR PARTICLE THERAPY-RELATED RESEARCH PROJECTS IS PROVIDING GROWTH OPPORTUNITIES IN RESEARCH APPLICATIONS

11. PARTICLE THERAPY MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. US
      • 11.2.1.1. Growing number of particle therapy centers in the US to drive market growth
    • 11.2.2. CANADA
      • 11.2.2.1. Canadian government undertaking initiatives to include particle therapy as a treatment method
  • 11.3. EUROPE
    • 11.3.1. FRANCE
      • 11.3.1.1. Increasing healthcare expenditure in France is supporting the adoption of particle therapy products
    • 11.3.2. GERMANY
      • 11.3.2.1. Increasing research in the field of proton & heavy ion therapy to drive the growth of the particle therapy market in Germany
    • 11.3.3. UK
      • 11.3.3.1. Cyclotrons segment dominated the particle therapy market in the UK
    • 11.3.4. REST OF EUROPE
  • 11.4. ASIA PACIFIC
    • 11.4.1. JAPAN
      • 11.4.1.1. Japan is the largest user of heavy ion therapy for the treatment of various types of cancers
    • 11.4.2. CHINA
      • 11.4.2.1. Growing interest of major market players to increase their presence in China will drive the growth of the particle therapy market in the country
    • 11.4.3. INDIA
      • 11.4.3.1. Leading product manufacturers are entering the Indian particle therapy market owing to the high growth opportunities in the country
    • 11.4.4. REST OF ASIA PACIFIC
  • 11.5. REST OF THE WORLD
    • 11.5.1. INADEQUATE HEALTHCARE INFRASTRUCTURE IS RESTRAINING THE WIDESPREAD ADOPTION OF PARTICLE THERAPY IN THE REGION

12. COMPETITIVE LANDSCAPE

  • 12.1. INTRODUCTION
  • 12.2. MARKET SHARE ANALYSIS
  • 12.3. COMPETITIVE SCENARIO
    • 12.3.1. PRODUCT LAUNCHES AND APPROVALS
    • 12.3.2. ACQUISITIONS
    • 12.3.3. EXPANSIONS
    • 12.3.4. AGREEMENTS AND COLLABORATIONS

13. COMPANY PROFILES: PARTICLE THERAPY MARKET (Business Overview, Products Offered, Recent Developments, MnM View)*

  • 13.1. VARIAN MEDICAL SYSTEMS, INC.
  • 13.2. ION BEAM APPLICATIONS SA (IBA)
  • 13.3. MEVION MEDICAL SYSTEMS, INC.
  • 13.4. PROVISION HEALTHCARE, LLC
  • 13.5. SUMITOMO HEAVY INDUSTRIES, LTD.
  • 13.6. HITACHI, LTD.
  • 13.7. OPTIVUS PROTON THERAPY, INC.
  • 13.8. PROTOM INTERNATIONAL, INC.
  • 13.9. ADVANCED ONCOTHERAPY PLC.
  • 13.10. DANFYSIK A/S

*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

14. APPENDIX

  • 14.1. DISCUSSION GUIDE
  • 14.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3. AVAILABLE CUSTOMIZATIONS
  • 14.4. RELATED REPORTS
  • 14.5. AUTHOR DETAILS
Back to Top